Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

The Significance of Accelerated Approval to Rare Disease Drug Development

Emil Kakkis, MD, PhD. , CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.